deltatrials
Completed PHASE2 NCT00000527

Recurrent Carotid Stenosis

Sponsor: Emory University

Conditions Cardiovascular Diseases Carotid Stenosis Cerebrovascular Disorders Heart Diseases Vascular Diseases
Interventions aspirin dipyridamole
Updated 5 times since 2017 Last updated: Dec 9, 2013 Started: Aug 31, 1986 Primary completion: Nov 30, 1998 Completion: Nov 30, 1998

Listed as NCT00000527, this PHASE2 trial focuses on Cardiovascular Diseases and Carotid Stenosis and remains completed. Sponsored by Emory University, it has been updated 5 times since 1986, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Aug 1986

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Emory University
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.